has landed a contract with GlaxoSmithKline to provide the pharmaceutical giant with microarray-based genotyping services. Other WRAL Top Stories Microarray technology enables researchers to genetic ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass., October 15, ...
Phoenix, AZ, March 28, 2007—The NIH Neuroscience Microarray Consortium today announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services.
Giant Cell Arteritis (GCA) is the most common vasculitis affecting the elderly. Archived formalin-fixed paraffin-embedded (FFPE) temporal artery biopsy (TAB) specimens potentially represent a valuable ...
To map most of the genetic variation in the human genome, scientists need to look at several hundred thousand single nucleotide polymorphisms (SNPs) per individual. Most genotyping assays employ ...
HOUSTON--(BUSINESS WIRE)--iGenomX International Genomics Corp., provider of the industry’s most scalable sequencing library tools, today launched its Next-Generation Genotyping (NGG) application for ...
Persistent Doubts about Reproducibility and Compatability of Data Are Being Overcome One of the hottest research tools these days within the academic, biotech, and pharma communities is DNA ...
Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic platform that can help close vaccination gaps and quickly detect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback